Market research
BAYN.F Bayer Aktiengesellschaft
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 47B
- P/E ratio
- Not available
- Analyst target
- 56.8333
- Dividend yield
- 0.2%
- Beta
- 0.83
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- ISIN
- DE000BAY0017
- Market cap
- 47B
- P/E ratio
- Not available
- Analyst target
- 56.8333
- Dividend yield
- 0.2%
- Beta
- 0.83
About
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the BAYN.F discussion.
5 years, 5 months ago
Bayer Aktiengesellschaft is currently in a long term downtrend where the price is trading 0.1% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.3.
Bayer Aktiengesellschaft's total revenue sank by 7.0% to $10B since the same quarter in the previous year.
Its net income has dropped by 78.2% to $308M since the same quarter in the previous year.
Finally, its free cash flow fell by 106.5% to $-142M since the same quarter in the previous year.
Based on the above factors, Bayer Aktiengesellschaft gets an overall score of 1/5.